The absence of NRP-1 in CD4+ T cells led to the activation of an anti-tumor immune response in melanoma-bearing mice, as evidenced by an increase in CD8+ T cells and a decrease in Tregs within the TME. This evidence concerns the gene NRP1 and neoplasm.